Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
30.16
+1.26 (4.36%)
At close: May 4, 2026, 4:00 PM EDT
30.16
0.00 (0.00%)
After-hours: May 4, 2026, 4:01 PM EDT
Eton Pharmaceuticals Employees
Eton Pharmaceuticals had 44 employees as of December 31, 2025. The number of employees increased by 13 or 41.94% compared to the previous year.
Employees
44
Change (1Y)
13
Growth (1Y)
41.94%
Revenue / Employee
$1,817,045
Profits / Employee
-$104,568
Market Cap
825.17M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 44 | 13 | 41.94% |
| Dec 31, 2024 | 31 | 1 | 3.33% |
| Dec 31, 2023 | 30 | 2 | 7.14% |
| Dec 31, 2022 | 28 | 11 | 64.71% |
| Dec 31, 2021 | 17 | 1 | 6.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evotec SE | 4,467 |
| Tilray Brands | 2,842 |
| Amphastar Pharmaceuticals | 1,976 |
| Alvotech | 1,279 |
| Pacira BioSciences | 829 |
| Cronos Group | 610 |
| Collegium Pharmaceutical | 423 |
| Esperion Therapeutics | 294 |
ETON News
- 3 days ago - Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution - GlobeNewsWire
- 7 days ago - Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700 - GlobeNewsWire
- 18 days ago - Eton Pharmaceuticals Announces CFO Succession Plan - GlobeNewsWire
- 6 weeks ago - Eton Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 6 weeks ago - Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026 - GlobeNewsWire
- 2 months ago - Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution - GlobeNewsWire
- 2 months ago - US FDA approves Eton Pharma's hormonal disorder drug - Reuters